Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: sulindac|OTHER: laboratory biomarker analysis
Sponsor: National Cancer Institute (NCI)
Collaborators: University of Arizona